Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities:    
Net loss $ (7,158) $ (193)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 202 178
Share-based compensation expense 191 146
Impairment charge 3,577 0
Gain on sale of equipment (6) 0
Changes in operating assets and liabilities:    
Accounts receivable 1,268 964
Inventory (1,659) (1,222)
Accounts payable 1,097 2
Accrued advertising and other allowances 319 (67)
Other operating assets and liabilities, net 691 473
Net cash provided by (used in) operating activities (1,478) 281
Cash flows from investing activities:    
Capital expenditures (122) (324)
Proceeds from the sale of equipment 6 0
Net cash used in investing activities (116) (324)
Cash flows from financing activities:    
Proceeds from the exercise of stock options 0 27
Proceeds from issuance of common stock 4,909 195
Net cash provided by financing activities 4,909 222
Net increase in cash and cash equivalents 3,315 179
Cash and cash equivalents at beginning of period 1,638 572
Cash and cash equivalents at end of period 4,953 751
Supplemental disclosure of cash flow information:    
Treasury stock acquired pursuant to a settlement agreement $ 5,105 $ 0